/ 2024-04-29T11:08:51+00:00 1.00 /about-us 2024-04-29T11:08:51+00:00 0.80 /about-us/onecipla-credo 2024-04-29T11:08:51+00:00 0.80 /about-us/board-directors 2024-04-29T11:08:51+00:00 0.80 /about-us/board-directors/committees-board 2024-04-29T11:08:51+00:00 0.80 /about-us/management-council 2024-04-29T11:08:51+00:00 0.80 /cipla-sustainability 2024-04-29T11:08:51+00:00 0.80 /about-us/manufacturing 2024-04-29T11:08:51+00:00 0.80 /about-us/quality 2024-04-29T11:08:51+00:00 0.80 /about-us/code-conduct 2024-04-29T11:08:51+00:00 0.80 /about-us/cipla-archive 2024-04-29T11:08:51+00:00 0.80 /about-us/milestones-and-awards 2024-04-29T11:08:51+00:00 0.80 /our-presence/australia 2024-04-29T11:08:51+00:00 0.80 /our-presence/brazil 2024-04-29T11:08:51+00:00 0.80 /our-presence/europe 2024-04-29T11:08:51+00:00 0.80 /cipla-malaysia 2024-04-29T11:08:51+00:00 0.80 /cipla-morocco 2024-04-29T11:08:51+00:00 0.80 /cipla-nepal 2024-04-29T11:08:51+00:00 0.80 /cipla-srilanka 2024-04-29T11:08:51+00:00 0.80 /our-offerings 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/respiratory 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/respiratory/asthma 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/respiratory/paediatric-asthma 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/respiratory/copd 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/respiratory/nebulization 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/hiv-aids 2024-04-29T11:08:51+00:00 0.80 /our-offerings/our-therapies/oncology 2024-04-29T11:08:51+00:00 0.80 /our-offerings/cipla-generics 2024-04-29T11:08:51+00:00 0.80 /our-offerings/cipla-generics/easylax 2024-04-29T11:08:51+00:00 0.80 /our-offerings/cipla-generics/easylax-l 2024-04-29T11:08:51+00:00 0.80 /cipla-diagnostics 2024-04-29T11:08:51+00:00 0.80 /our-offerings/api 2024-04-29T11:08:51+00:00 0.80 /covid-care 2024-04-29T11:08:51+00:00 0.80 /investors 2024-04-29T11:08:51+00:00 0.80 /investors/quarterly-results 2024-04-29T11:08:51+00:00 0.80 /investors/investor-presentation 2024-04-29T11:08:51+00:00 0.80 /investors/annual-reports 2024-04-29T11:08:51+00:00 0.80 /investors/scheme-arrangement 2024-04-29T11:08:51+00:00 0.80 /investors/corporate-governance 2024-04-29T11:08:51+00:00 0.80 /disclosures-under-regulation-46-lodr 2024-04-29T11:08:51+00:00 0.80 /investors/investor-resources 2024-04-29T11:08:51+00:00 0.80 /investors/shareholding-pattern 2024-04-29T11:08:51+00:00 0.80 /investors/intimation-stock-exchanges 2024-04-29T11:08:51+00:00 0.80 /investors/unclaimed-data 2024-04-29T11:08:51+00:00 0.80 /investors/investor-contacts 2024-04-29T11:08:51+00:00 0.80 /investors/disclaimer 2024-04-29T11:08:51+00:00 0.80 /careers 2024-04-29T11:08:51+00:00 0.80 /careers/cipla-university 2024-04-29T11:08:51+00:00 0.80 /media-centre 2024-04-29T11:08:51+00:00 0.80 /media-centre/media-releases 2024-04-29T11:08:51+00:00 0.80 /media-centre/news 2024-04-29T11:08:51+00:00 0.80 /leaders-speak 2024-04-29T11:08:51+00:00 0.80 /csr/cipla-foundation/ 2023-09-15T06:05:32+00:00 0.80 /sites/default/files/2023-05/Corporate-Social-Responsibility-Policy.pdf 2023-09-13T06:26:35+00:00 0.80 /sites/default/files/Annual-Action-Plan-FY23-24.pdf 2024-01-30T13:27:11+00:00 0.80 /sites/default/files/Approved-CSR-Projects-22-23.pdf 2023-09-13T05:33:06+00:00 0.80 /sites/default/files/Approved-CSR-Projects-2021-2022.pdf 2023-09-13T05:33:06+00:00 0.80 /contact-us 2024-04-29T11:08:51+00:00 0.80 /sites/default/files/Annual-Report-FY-2022-23-Double-page.pdf 2023-09-13T05:32:52+00:00 0.80 /sites/default/files/bet9��-Q3FY24-Press-Release.pdf 2024-01-22T18:20:39+00:00 0.80 /sites/default/files/Q2-FY24-Press-Release.pdf 2023-10-27T10:31:01+00:00 0.80 /sites/default/files/bet9��-Q1FY24-Press-Release.pdf 2023-09-13T05:34:53+00:00 0.80 /sites/default/files/Q4-FY23-Press-Release.pdf 2023-09-13T05:57:36+00:00 0.80 /careers/life-cipla 2024-04-29T11:08:51+00:00 0.80 /csr/cipla-foundation/health.html 2023-12-19T10:10:51+00:00 0.80 /sites/default/files/Approved-CSR-Projects.pdf 2023-09-13T05:33:07+00:00 0.80 /careers/culture-and-values 2024-04-29T11:08:51+00:00 0.80 /privacy-policy 2024-04-29T11:08:51+00:00 0.80 /sitemap 2024-04-29T11:08:51+00:00 0.80 /caution-notice-recruitment-fraud 2024-04-29T11:08:51+00:00 0.80 /dsafe.html 2024-04-05T10:21:50+00:00 0.80 /sites/default/files/Covid/SUPPLY-DETAILS-OF-REMDESIVIR-TO-THE-STATE-OF-MAHARASHTRA.pdf 2023-09-13T06:26:54+00:00 0.80 /about-us/our-history 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Charter-Of-The-Audit-Committee.pdf 2023-09-13T05:34:11+00:00 0.64 /sites/default/files/Charter-of-The-Nomination-and-Remuneration-Committee.pdf 2023-11-22T07:17:12+00:00 0.64 /sites/default/files/2022-04/Charter-of-the-corporate-social-responsibility-committee.pdf 2023-09-13T06:24:25+00:00 0.64 /sites/default/files/2023-05/Charter-Of-The-Stakeholders-Relationship-Committee.pdf 2023-09-13T06:26:34+00:00 0.64 /sites/default/files/2023-05/Charter-Of-The-Investment-Risk-Management-committee.pdf 2023-09-13T06:26:34+00:00 0.64 /sites/default/files/2019-08/Charter-of-the-Operations-and-Administrative-Commitee.pdf 2023-09-13T06:06:02+00:00 0.64 /sites/default/files/bet9��-Biodiversity-commitment-to-IBBI.pdf 2023-09-13T05:34:40+00:00 0.64 /sites/default/files/bet9��-Task-Force-on-Climate-Related-Financial-Disclosures-Report.pdf 2023-09-13T05:35:04+00:00 0.64 /cipla-sustainability?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Dec-2023/Half-yearly-EC-Compliance-Report-Kurkumbh-I.pdf 2023-12-29T11:19:50+00:00 0.64 /sites/default/files/Dec-2023/Half-yearly-EC-Compliance-Report-Kurkumbh-II.pdf 2023-12-29T11:19:29+00:00 0.64 /sites/default/files/Dec-2023/Half-yearly-EC-Compliance-Report-Kurkumbh-III.pdf 2023-12-29T11:18:41+00:00 0.64 /sites/default/files/manufacturing-pdf-oct-2023/Environment-Statement-22-23-Kurkumbh-Unit-I.pdf 2023-10-16T07:29:26+00:00 0.64 /sites/default/files/manufacturing-pdf-oct-2023/Environment-Statment-22-23-Kurkumbh-Unit-II.pdf 2023-10-16T07:37:27+00:00 0.64 /sites/default/files/manufacturing-pdf-oct-2023/Environmental-statement-22-23-Kurkumbh-Unit-III.pdf 2023-10-16T07:27:53+00:00 0.64 /sites/default/files/Dec-2023/Half-yearly-EC-Compliance-Report-Virgonagar.pdf 2023-12-29T11:17:29+00:00 0.64 /sites/default/files/Dec-2023/Half-yearly-EC-Compliance-Report-Bommasandra.pdf 2023-12-29T11:16:10+00:00 0.64 /sites/default/files/EC_Bommansandra.pdf 2023-09-13T05:36:45+00:00 0.64 /sites/default/files/Mandoli-depot-complaince.pdf 2023-09-13T05:55:47+00:00 0.64 /sites/default/files/manufacturing-pdf-oct-2023/Environment-Statement%2022-23-Bommasandra.pdf 2023-10-16T06:44:19+00:00 0.64 /sites/default/files/manufacturing-pdf-oct-2023/Environment-Statement-22-23-Virgonagar.pdf 2023-10-16T06:44:19+00:00 0.64 /cipla-contractor-compliance-documents-adecco 2024-04-29T11:08:51+00:00 0.64 /cipla-contractor-compliance-documents-crekk 2024-04-29T11:08:51+00:00 0.64 /cipla-contractor-compliance-documents-genuis 2024-04-29T11:08:51+00:00 0.64 /cipla-contractor-compliance-documents-bcl 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/2019-02/bet9��-Code-of-Conduct.PDF 2023-09-13T06:03:29+00:00 0.64 /sites/default/files/2019-02/Whistle-Blower_0.pdf 2023-09-13T06:03:52+00:00 0.64 /about-us/cipla-archive/explore 2024-04-29T11:08:51+00:00 0.64 /about-us/milestones-and-awards?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/bet9��-Deferasirox-Healthcare-Professionals-Guide.pdf 2024-01-12T10:00:16+00:00 0.64 /sites/default/files/bet9��-Deferasirox-Patient-Guide.pdf 2024-01-12T10:00:16+00:00 0.64 /sites/default/files/bet9��-Ambrisentan-Information-Leaflet-for-Prescriber.pdf 2024-01-12T10:01:09+00:00 0.64 /sites/default/files/bet9��-Ambrisentan-Patient-Information-Card.pdf 2024-01-12T10:01:09+00:00 0.64 /sites/default/files/bet9��-Adalimumab-Patient-Reminder-Cards-ADULT.pdf 2023-11-20T12:56:34+00:00 0.64 /sites/default/files/2023-11/bet9��-Adalimumab-Patient-Reminder-Cards-PAEDIATRIC.pdf 2023-11-20T12:59:56+00:00 0.64 /sites/default/files/2023-07/bet9��-Lenalidomide-Information-Brochure-for-HCP-v2.pdf 2023-09-13T06:26:43+00:00 0.64 /sites/default/files/2023-07/bet9��-Lenalidomide-Patient-Brochure-v2.pdf 2023-09-13T06:26:43+00:00 0.64 /sites/default/files/2023-07/bet9��-Lenalidomide-Patient-card-v2.pdf 2023-09-13T06:26:44+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20initiation%20checklist%20Combined.pdf 2023-09-13T05:34:19+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Treatment%20Initiation%20form-Male%20patients.pdf 2023-09-13T05:34:20+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Treatment%20Initiation%20form-Women%20of%20Child%20Bearing%20Potential.pdf 2023-09-13T05:34:21+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Treatment%20Initiation%20form-Women%20of%20Non%20Child%20Bearing%20Potential.pdf 2023-09-13T05:34:21+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Pharmacy%20Registration%20Form.pdf 2023-09-13T05:34:19+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Prescription%20Authorisation%20Form.pdf 2023-09-13T05:34:20+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Adverse%20Event%20Form.pdf 2023-09-13T05:34:18+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Pregnancy%20Outcome%20Form.pdf 2023-09-13T05:34:19+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Pregnancy%20Reporting%20Form.pdf 2023-09-13T05:34:20+00:00 0.64 /sites/default/files/bet9��%20Lenalidomide%20Caregiver%20guide.pdf 2023-09-13T05:34:18+00:00 0.64 /sites/default/files/bet9��-Fingolimod-Patient-Parent-Caregivers-guide.pdf 2023-09-13T05:34:44+00:00 0.64 /sites/default/files/bet9��-Fingolimod-Physicians-checklist.pdf 2023-09-13T05:34:45+00:00 0.64 /sites/default/files/bet9��-Fingolimod-Pregnancy-specific-patient-reminder-card.pdf 2023-09-13T05:34:46+00:00 0.64 /sites/default/files/bet9��-Brazil/Guidance-on-adverse-event-reporting-English.pdf 2023-09-13T06:26:51+00:00 0.64 /sites/default/files/bet9��-Brazil/Adverse-Event-Form-English.pdf 2023-09-13T06:26:51+00:00 0.64 /sites/default/files/UK-Tax-Strategy-2022.pdf 2023-09-13T05:59:14+00:00 0.64 /sites/default/files/bet9��-UK-Tax-Strategy-FY2021.pdf 2023-09-13T05:35:04+00:00 0.64 /sites/default/files/bet9��%20-%20UK%20Tax%20Strategy%20-%20FY2020_u_0.pdf 2023-09-13T05:34:14+00:00 0.64 /sites/default/files/2020-03/bet9��_UK_Tax_Strategy_FY2019_0.pdf 2023-09-13T06:08:00+00:00 0.64 /sites/default/files/bet9��-uk-tax-strategy.pdf 2023-09-13T05:35:04+00:00 0.64 /sites/default/files/Ambrisentan-Spain-Patient-card.pdf 2023-09-13T05:32:09+00:00 0.64 /sites/default/files/Ambrisentan-Germany-Patient-card.pdf 2023-09-13T05:32:09+00:00 0.64 /sites/default/files/Bosentan_Spain.pdf 2023-09-13T05:33:28+00:00 0.64 /sites/default/files/2022-01/Patienten-Warnkarte.pdf 2023-09-13T06:23:58+00:00 0.64 /sites/default/files/Tenofovir-Spain_1.pdf 2023-09-13T05:59:09+00:00 0.64 /sites/default/files/Tenofovir-Spain_2.pdf 2023-09-13T05:59:09+00:00 0.64 /sites/default/files/SmPC_Tenofovir_Spain.pdf 2023-09-13T05:58:53+00:00 0.64 /sites/default/files/2021-07/ZUSAMMENFASSUNG-DER-MERKMALE-DES-ARZNEIMITTELS.pdf 2023-09-13T06:23:04+00:00 0.64 /sites/default/files/Methotrexate-Patient-Cards-Front-Side.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/Methotrexate-Patient-Cards-Back-Side.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/DHPC%20Methotrexate%20for%20autoimmune%20diseases.PDF 2023-09-13T05:36:02+00:00 0.64 /sites/default/files/Methotrexate%20%E2%80%93%20Prescribing%20and%20Dispensing%20Guide%20for%20Healthcare%20Professionals.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/Methotrexate%202.5%20mg%20%E2%80%93%20Patient%20Card%20-%20Risk%20Minimisation%20Information%20for%20Patients.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/Methotrexate%2010%20mg%20%E2%80%93%20Patient%20Card%20-%20Risk%20Minimisation%20Information%20for%20Patients.pdf 2023-09-13T05:55:50+00:00 0.64 /sites/default/files/metotreksat-tabl-pasientkort.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/metotreksat-tabl-sikkerhetsinfo-helsepersonell.pdf 2023-09-13T05:55:51+00:00 0.64 /sites/default/files/Lenalidomida-Tarjeta-Paciente.pdf 2023-09-13T05:55:10+00:00 0.64 /sites/default/files/Informaci%C3%B3n-dirigida.pdf 2023-09-13T05:54:52+00:00 0.64 /sites/default/files/Informaci%C3%B3n-importante-lenalidomida.pdf 2023-09-13T05:54:53+00:00 0.64 /sites/default/files/DESENLACE-DEL-EMBARAZO.pdf 2023-09-13T05:36:00+00:00 0.64 /sites/default/files/INFORME-INICIAL-DE-EMBARAZO.pdf 2023-09-13T05:54:55+00:00 0.64 /sites/default/files/Programa-de-Prevenci%C3%B3n-de-Embarazos-de-lenalidomida.pdf 2023-09-13T05:57:15+00:00 0.64 /sites/default/files/Formulario-de-conocimiento-del-riesgo-dirigido-a-pacientes.pdf 2023-09-13T05:54:34+00:00 0.64 /sites/default/files/FORMULARIO-DE-SEGUIMIENTO-DEL-NEONATO.pdf 2023-09-13T05:54:34+00:00 0.64 /sites/default/files/dirigido-a-pacientes-VARONES.pdf 2023-09-13T05:36:02+00:00 0.64 /sites/default/files/Lista-de-verificaci%C3%B3n-del-asesoramiento-sobre-el-Programa-de-Prevenci%C3%B3n.pdf 2023-09-13T05:55:41+00:00 0.64 /sites/default/files/2022-05/edumat_hcp_Lenalidomide_Leitfaden_Angehorige-Heilberufe.pdf 2023-09-13T06:24:36+00:00 0.64 /sites/default/files/Checkliste-fur-die-Beratung-gebarfahiger-Patientinnen.pdf 2023-09-13T05:34:12+00:00 0.64 /sites/default/files/2022-05/edumat_pat_Lenalidomide_Leitfaden_patienten.pdf 2023-09-13T06:24:36+00:00 0.64 /sites/default/files/edumat-hcp-Lenalidomide-Einverst%C3%A4ndniserkl%C3%A4rung.pdf 2023-09-13T05:36:49+00:00 0.64 /sites/default/files/edumat-hcp-Lenalidomide-Exposition-Schwangerschaft.pdf 2023-09-13T05:36:49+00:00 0.64 /sites/default/files/edumat-pat-Lenalidomide-Patientenkarte.pdf 2023-09-13T05:36:49+00:00 0.64 /sites/default/files/Lenalidomide-Formular-Berichte-unerw%C3%BCnschte-Ereignisse.pdf 2023-09-13T05:55:10+00:00 0.64 /sites/default/files/Broschyr-for-halso-och-sjukvardspersonal.pdf 2023-09-13T05:33:29+00:00 0.64 /sites/default/files/Checklista.pdf 2023-09-13T05:34:12+00:00 0.64 /sites/default/files/Formular-for-Biverkningsrapportering.pdf 2023-09-13T05:54:33+00:00 0.64 /sites/default/files/Formular-vid-graviditet.pdf 2023-09-13T05:54:34+00:00 0.64 /sites/default/files/Patientbroschyr.pdf 2023-09-13T05:56:43+00:00 0.64 /sites/default/files/Patientkort.pdf 2023-09-13T05:56:45+00:00 0.64 /press-releases-statements/cipla-stands-strong-india-battle-against-covid-19 2024-04-29T11:08:51+00:00 0.64 /helping-millions-breathe-free 2024-04-29T11:08:51+00:00 0.64 /our-offerings/our-therapies/respiratory/blow-art-paintings 2024-04-29T11:08:51+00:00 0.64 /latest-respiratory-article/cipla-enters-licensing-agreement-gilead-expand-access-covid-19-treatment 2024-04-29T11:08:51+00:00 0.64 /latest-respiratory-article/cipla-files-anda-generic-version-gsks-advair-diskusr 2024-04-29T11:08:51+00:00 0.64 /latest-respiratory-article/cipla-announces-successful-completion-phase-3-clinical-study-generic 2024-04-29T11:08:51+00:00 0.64 /latest-respiratory-article/cipla-receives-final-approval-generic-version-proventilr-hfa-inhalation 2024-04-29T11:08:51+00:00 0.64 /our-offerings/our-therapies/respiratory/asthma?page=1 2024-04-29T11:08:51+00:00 0.64 /our-offerings/our-therapies/respiratory/copd/lung-attack 2024-04-29T11:08:51+00:00 0.64 /our-offerings/our-therapies/respiratory/breathefree 2024-04-29T11:08:51+00:00 0.64 /our-offerings/our-therapies/respiratory/nebulization/gnp 2024-04-29T11:08:51+00:00 0.64 /key-behaviours-while-nebulizing/safety-first 2024-04-29T11:08:51+00:00 0.64 /key-behaviours-while-nebulizing/refuse-reuse 2024-04-29T11:08:51+00:00 0.64 /key-behaviours-while-nebulizing/mind-gap 2024-04-29T11:08:51+00:00 0.64 /key-behaviours-while-nebulizing/sanitize-nebulize 2024-04-29T11:08:51+00:00 0.64 /cipla-diagnostics/cippoint 2024-04-29T11:08:51+00:00 0.64 /themes/cipla/pdf_ciptest/CipTest-Dengue.pdf 2023-09-08T06:43:26+00:00 0.64 /themes/cipla/pdf_ciptest/CipTest-Malaria.pdf 2023-09-08T06:43:42+00:00 0.64 /themes/cipla/pdf_ciptest/CipTest-HIV.pdf 2023-09-08T06:43:38+00:00 0.64 /themes/cipla/pdf_ciptest/CipTest-Hepatitis-C.pdf 2023-09-08T06:43:38+00:00 0.64 /themes/cipla/pdf_ciptest/CipTest-HBsAg.pdf 2023-09-08T06:43:34+00:00 0.64 /cipla-diagnostics/ciptest 2024-04-29T11:08:51+00:00 0.64 /covid-care/antibody-cocktail 2024-04-29T11:08:51+00:00 0.64 /cipla-foundation/covid-care 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Annual-Report-FY-2022-23.pdf 2023-09-13T05:32:53+00:00 0.64 /sites/default/files/Annual-Report-2021-22-double-page.pdf 2023-09-13T05:32:44+00:00 0.64 /sites/default/files/Q3-FY24-Investor-Presentation.pdf 2024-01-22T18:25:15+00:00 0.64 /sites/default/files/Q2-FY24-Investor-Presentation.pdf 2023-10-27T10:26:49+00:00 0.64 /sites/default/files/Q1-FY24-Investor-presentation.pdf 2023-09-13T05:57:33+00:00 0.64 /sites/default/files/Q4-FY23-Investor-Presentation.pdf 2023-09-13T05:57:36+00:00 0.64 /sites/default/files/Earnings-Call-Transcript-Q3-FY24.pdf 2024-01-29T09:34:39+00:00 0.64 /sites/default/files/Newspaper-Publication-Q3Y24.pdf 2024-01-22T13:56:41+00:00 0.64 /sites/default/files/Unaudited-financial-Result-Standalone-and-Consolidated-for-the-quarter-ended-31st-December-2023.pdf 2024-01-22T13:48:14+00:00 0.64 /sites/default/files/Earnings-Call-Transcript-Q2-FY24.pdf 2023-10-31T13:00:51+00:00 0.64 /sites/default/files/Disclosure-of-Related-Party-Transactions-for-the-half-year-ended-30th-September-2023.pdf 2023-10-28T17:29:54+00:00 0.64 /sites/default/files/Newspaper-publication-Q2FY24.pdf 2023-10-27T09:37:15+00:00 0.64 /sites/default/files/Unaudited-financial-Result-Standalone-and-Consolidated-for-the-quarter-ended-30th-September-2023.pdf 2023-10-27T09:28:12+00:00 0.64 /sites/default/files/Earnings-Call-Transcript-Q1-FY24.pdf 2023-09-13T05:36:19+00:00 0.64 /sites/default/files/Extract-of-Unaudited-Consolidated-Financial-Results-30th-July-2023.pdf 2023-09-13T05:37:06+00:00 0.64 /sites/default/files/Unaudited-financial-Result-Standalone-and-Consolidated-for-the-quarter-ended-30th-June-2023.pdf 2023-09-13T05:59:24+00:00 0.64 /sites/default/files/Machine-readable-version-of-audited-financial-results.pdf 2023-09-13T05:55:49+00:00 0.64 /sites/default/files/Transcript-Q4FY23-Audited-Financial-Results-31March2023.pdf 2023-09-13T05:59:12+00:00 0.64 /sites/default/files/Disclosure-of-Related-Party-Transactions-for-the-half-year-ended-31st-March-2023.pdf 2023-09-13T05:36:03+00:00 0.64 /audio/9060 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Extracts-of-Audited-consolidated-Financial-Results-31st-March-2023.pdf 2023-09-13T05:37:08+00:00 0.64 /sites/default/files/Financial-results-March-2023-signed.pdf 2023-09-13T05:39:18+00:00 0.64 /press-releases-statements/bet9��-Health-strengthens-its-play-in-beauty-and-personal-care 2024-04-29T11:08:51+00:00 0.64 /press-releases-statements/Sanofi-and-bet9��-announce-exclusive-distribution-partnership-to-expand-reach-of-CNS-portfolio-in-India 2024-04-29T11:08:51+00:00 0.64 /press-releases-statements/bet9��-strengthens-fight-against-AMR-secures-approval-to-introduce-ZEMDRI-injection-in-India 2024-04-29T11:08:51+00:00 0.64 /press-releases-statements/cipla-partners-with-csir-cdri-to-advance-ophthalmic-antifungal-treatment-development 2024-04-29T11:08:51+00:00 0.64 /audio/9455 2024-04-29T11:08:51+00:00 0.64 /audio/9581 2024-04-29T11:08:51+00:00 0.64 /audio/11454 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/GCFO-GCSO-Presentation-at-Nuvama-India-Conference-2024.pdf 2024-02-13T05:36:31+00:00 0.64 /sites/default/files/Record_of_Investor_Meetings_December_2023.pdf 2024-02-19T14:14:24+00:00 0.64 /sites/default/files/Record_of_Investor_Meetings_September_2023.pdf 2024-02-19T14:02:53+00:00 0.64 /sites/default/files/Record_of_Investor_Meetings_August_2023.pdf 2024-02-19T14:05:06+00:00 0.64 /sites/default/files/Notice-of-Annual-General-Meeting-2023.pdf 2023-09-13T05:56:27+00:00 0.64 /sites/default/files/Scrutinizer-report-of-the-87th-Annual-General-Meeting.pdf 2023-09-13T05:58:29+00:00 0.64 /sites/default/files/Address-by-Chairman-at-the-87th-Annual-General-Meeting.pdf 2023-09-13T05:31:47+00:00 0.64 /sites/default/files/Presentation-by-MrUmangVohra-MD-GCEO.pdf 2023-09-20T07:45:25+00:00 0.64 /sites/default/files/Transcript-of-the-87th-Annual-General-Meeting.pdf 2023-09-13T05:59:11+00:00 0.64 /sites/default/files/Information-under-section-of-the-Companies-Act.pdf 2023-09-13T05:54:55+00:00 0.64 /sites/default/files/Business-Responsibility-Sustainability-Report.pdf 2023-09-13T05:33:29+00:00 0.64 /sites/default/files/Annual-Return-2022-23.pdf 2023-09-13T05:32:56+00:00 0.64 /investors/annual-reports?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/NOC-NSE.pdf 2023-09-13T05:56:08+00:00 0.64 /sites/default/files/NOC-BSE.pdf 2023-09-13T05:56:08+00:00 0.64 /sites/default/files/ReportsoncomplaintsBSE.pdf 2023-09-13T05:58:04+00:00 0.64 /sites/default/files/ReportsoncomplaintsNSE.pdf 2023-09-13T05:58:04+00:00 0.64 /sites/default/files/Accounting%20treatment%20certificate%20from%20auditors%20for%20all%20the%20companies%20involved%20in%20the%20Scheme.pdf 2023-09-13T05:31:45+00:00 0.64 /sites/default/files/Audited-financial-numbers-of-CBL-and-CHL.pdf 2023-09-13T05:33:15+00:00 0.64 /sites/default/files/Auditor-Certificate-certifying-the-non-applicability-of-Part-I-A-10-a-read-with-conditions-prescribed.pdf 2023-09-13T05:33:19+00:00 0.64 /sites/default/files/Compliance%20Report%20.pdf 2023-09-13T05:35:18+00:00 0.64 /sites/default/files/Draft%20Scheme.pdf 2023-09-13T05:36:21+00:00 0.64 /sites/default/files/Fairness%20Opinion.pdf 2023-09-13T05:37:08+00:00 0.64 /investors/scheme-arrangement?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/2019-01/Corporate%20Responsibility%20Policy.pdf 2023-09-13T06:01:18+00:00 0.64 /sites/default/files/2021-09/Policy-for-Preservation-of-Documents.pdf 2023-09-13T06:23:28+00:00 0.64 /sites/default/files/2023-02/Policy-on-Related-Party-Transaction_Revised-%20Final.pdf 2023-09-13T06:26:12+00:00 0.64 /sites/default/files/2021-06/Nomination-Remuneration-and-Board-Diversity-Policy.pdf 2023-09-13T06:22:38+00:00 0.64 /sites/default/files/2023-07/EHS-Policy-2023.pdf 2023-09-13T06:26:44+00:00 0.64 /sites/default/files/2019-06/1554391523_1530187477_Conflict%20of%20Interest%20Policy%20-%20V1%20fc.pdf 2023-09-13T06:04:59+00:00 0.64 /sites/default/files/2023-05/Whistle-Blower-Policy.pdf 2023-09-13T06:26:36+00:00 0.64 /sites/default/files/Risk-Management-Policy.pdf 2023-09-13T05:58:10+00:00 0.64 /sites/default/files/2019-06/1553587611_Anti-Trust-and-Fair-Competition-Policy.pdf 2023-09-13T06:04:58+00:00 0.64 /sites/default/files/2023-07/Data-Privacy-Management-Policy.pdf 2023-09-13T06:26:44+00:00 0.64 /sites/default/files/2023-07/Equal-Opportunity-Policy.pdf 2023-09-13T06:26:45+00:00 0.64 /sites/default/files/2019-06/1553587868_Anti-Bribery-and-Anti-Corruption-Policy.pdf 2023-09-13T06:04:59+00:00 0.64 /sites/default/files/2023-05/Dividend-Distribution-Policy.pdf 2023-09-13T06:26:35+00:00 0.64 /sites/default/files/2023-07/Policy-for-determination-of-materiality-of-events-or-information.pdf 2023-09-13T06:26:46+00:00 0.64 /sites/default/files/2019-01/Archival%20Policy.pdf 2023-09-13T06:00:48+00:00 0.64 /sites/default/files/2020-04/Material%20subsidiary%20policy_v6_final.pdf 2023-09-13T06:08:59+00:00 0.64 /sites/default/files/2023-07/Human-Rights-Policy.pdf 2023-09-13T06:26:46+00:00 0.64 /sites/default/files/1558508425_POSH-%20bet9��.pdf 2023-09-13T05:31:20+00:00 0.64 /sites/default/files/2023-08/bet9��-UK-Tax-Strategy-2023.pdf 2023-09-13T06:26:49+00:00 0.64 /sites/default/files/2019-01/MOA-AOA.pdf 2023-09-13T06:01:38+00:00 0.64 /sites/default/files/1530274684_bet9��---Code-of-Conduct-FC.PDF.pdf 2023-09-13T05:29:30+00:00 0.64 /sites/default/files/2020-08/Insider%20Trading%20Code.pdf 2023-09-13T06:16:33+00:00 0.64 /sites/default/files/2023-07/Code-of-fair-disclosure-of-unpublished-price-sensitive-information.pdf 2023-09-13T06:26:44+00:00 0.64 /sites/default/files/Tax-Transparency-Report-for-FY2022-23.pdf 2023-09-13T05:59:02+00:00 0.64 /sites/default/files/Tax-Transparency-Report-FY2021-22.pdf 2023-09-13T05:59:04+00:00 0.64 /sites/default/files/Tax-Transparency-Report-for-FY2020-21.pdf 2023-09-13T05:59:02+00:00 0.64 /sites/default/files/2020-09/Terms%20and%20Conditions%20of%20appointment%20of%20independent%20directors.pdf 2023-09-13T06:17:10+00:00 0.64 /sites/default/files/2023-06/Details-of-Familiarisation-Programme-imparted-to-Independent-Director-FY-2022-23.pdf 2023-09-13T06:26:39+00:00 0.64 /sites/default/files/Details-of-Familiarisation-programme-imparted-to-Independent-Director-FY-2021-22.pdf 2023-09-13T05:36:01+00:00 0.64 /sites/default/files/Details-of-Familiarisation-programme-imparted-to-Independent-Director-FY-2020-21.pdf 2023-09-13T05:36:01+00:00 0.64 /sites/default/files/2020-05/Familiriasation%20Programme%202019-20%20updated.pdf 2023-09-13T06:10:53+00:00 0.64 /sites/default/files/Familiriasation_Programme.pdf 2023-09-13T05:37:09+00:00 0.64 /sites/default/files/Details%20of%20Familiarisation%20programme%20imparted%20to%20Independent%20Director.pdf 2023-09-13T05:36:01+00:00 0.64 /sites/default/files/2016-2017.pdf 2023-09-13T05:31:36+00:00 0.64 /sites/default/files/Details%20of%20Familarisation%20programme%20imparted%20to%20Independent%20Director%202016-2017.pdf 2023-09-13T05:36:00+00:00 0.64 /sites/default/files/1442998101_Familiarisation-programme-for-Independent-Directors_0.pdf 2023-09-13T05:27:28+00:00 0.64 /sites/default/files/Investor-Servicing-and-Grievance-Redrrssal-Policy.pdf 2023-09-13T05:55:03+00:00 0.64 /sites/default/files/Investor-FAQs.pdf 2023-09-13T05:55:02+00:00 0.64 /sites/default/files/forms-and-regulation/sebi-circular.pdf 2023-09-13T06:28:40+00:00 0.64 /sites/default/files/SEBI-CIRCULAR-DATED-DEC14-2021.pdf 2023-09-13T05:58:35+00:00 0.64 /sites/default/files/SEBI-CIRCULAR-DATED-JAN25-2022.pdf 2023-09-13T05:58:36+00:00 0.64 /sites/default/files/Details-of-the-SEBI-circular-dated-November-17-2023.pdf 2024-02-06T13:35:32+00:00 0.64 /sites/default/files/forms-and-regulation/Form-ISR-1.pdf 2023-09-13T06:28:39+00:00 0.64 /sites/default/files/forms-and-regulation/Form-ISR-2.pdf 2023-09-13T06:28:39+00:00 0.64 /sites/default/files/forms-and-regulation/Form-ISR-3.pdf 2023-09-13T06:28:39+00:00 0.64 /sites/default/files/forms-and-regulation/Form-ISR-4.pdf 2023-09-13T06:28:39+00:00 0.64 /sites/default/files/forms-and-regulation/Form-ISR-5.pdf 2023-09-13T06:28:40+00:00 0.64 /sites/default/files/forms-and-regulation/Form-SH-13.pdf 2023-09-13T06:28:40+00:00 0.64 /sites/default/files/forms-and-regulation/Form-SH-14.pdf 2023-09-13T06:28:40+00:00 0.64 /sites/default/files/2024-01/SEBI-Circular-on-Online-Resolution-of-Disputes-in-the-Indian-Securities-Market-dated-31st-July-2023.pdf 2024-01-04T09:16:20+00:00 0.64 /sites/default/files/2024-01/SEBI-Circular-on-Corrigendum-cum-Amendment-to-Circular-dated-July-31-2023-on-Online-Resolution-of-Disputes-in-the-Indian-Securities-Market-dated-14th-August-2023.pdf 2024-01-04T09:18:28+00:00 0.64 /sites/default/files/2024-01/SEBI-Circular-on-Amendment-to-Circular-dated-July-31-2023-on-Online-Resolution-of-Disputes-in-the-Indian-Securities-Market-dated-20th-December-2023.pdf 2024-01-04T09:20:23+00:00 0.64 /sites/default/files/2024-01/SEBI-Master-Circular-for-Online-Resolution-of-Disputes-in-the-Indian-Securities-Market.pdf 2024-01-04T09:36:33+00:00 0.64 /sites/default/files/Charter-of-the-Sustainability-Council-bet9��_1.pdf 2023-09-13T05:34:12+00:00 0.64 /sites/default/files/SSCM%20Code%20of%20Conduct-Final_1.pdf 2023-09-13T05:58:54+00:00 0.64 /sites/default/files/SSCM%20Policy-Final_1.pdf 2023-09-13T05:58:54+00:00 0.64 /sites/default/files/Annual-Secretarial-Compliance-Report-2022-23.pdf 2023-09-13T05:33:02+00:00 0.64 /sites/default/files/Annual-Secretarial-Compliance-Report-21-22.pdf 2023-09-13T05:33:01+00:00 0.64 /sites/default/files/Annual-Secretarial-Compliance-Report-20-21.pdf 2023-09-13T05:33:00+00:00 0.64 /sites/default/files/2022-09/Annual-Secretarial-Compliance-Report-19-20.pdf 2023-09-13T06:25:10+00:00 0.64 /sites/default/files/Annual-Secretarial-Compliance-Report-18-19.pdf 2023-09-13T05:32:57+00:00 0.64 /sites/default/files/Whistle-Blower-Policy.pdf 2023-09-13T05:59:55+00:00 0.64 /sites/default/files/IEPF-newspaper-publication.pdf 2023-09-13T05:54:54+00:00 0.64 /sites/default/files/Financial-Statements-of-Subsidiaries-FY-2022-23.pdf 2023-09-13T05:54:15+00:00 0.64 /sites/default/files/Stock-exchange-Intimation-under-Regulation.pdf 2023-09-13T05:58:56+00:00 0.64 /sites/default/files/Dividend-Distribution-Policy.pdf 2023-09-13T05:36:06+00:00 0.64 /sites/default/files/Appointment-of-Senior-Management-Personnel-RKSinha.pdf 2024-03-26T16:18:43+00:00 0.64 /sites/default/files/Sanofi-bet9��-announce-exclusive-distribution-partnership-to-expand-reach-of-CNS-portfolio-in-India.pdf 2024-03-26T14:34:53+00:00 0.64 /sites/default/files/Merger-of-bet9��-Technologies-LLC-USA-with-bet9��-USA-Inc.pdf 2024-03-26T14:02:17+00:00 0.64 /sites/default/files/GST-order-received-from-Office-of-the-Assistant-Commissioner-GST-Central-Excise-Cuttack-Odisha.pdf 2024-03-20T11:44:19+00:00 0.64 /sites/default/files/Appointment-of-Senior-Management-Personnel.pdf 2024-03-20T11:24:50+00:00 0.64 /sites/default/files/Allotment-of-1658-equity-shares-under-ESOS-2013-A-Scheme-and-bet9��-ESAR-Scheme-2021.pdf 2024-03-15T10:46:51+00:00 0.64 /sites/default/files/Sale-of-entire-stake-in-Wellthy-Therapeutics-Private-Limited.pdf 2024-03-06T18:31:12+00:00 0.64 /sites/default/files/Schedule-of-Analyst-Institutional-Investor-Meetings-06-Mar-2024.pdf 2024-03-06T18:25:57+00:00 0.64 /sites/default/files/GST-order-received-from-Office-of-the-Joint-Commissioner-Large-Taxpayer-Unit-Corporate-Division-West-Bengal.pdf 2024-03-06T07:37:05+00:00 0.64 /sites/default/files/Schedule-of-Analyst-Institutional-Investor-Meetings-05-Mar-2024.pdf 2024-03-05T13:20:37+00:00 0.64 /investors/investor-resources?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Shareholding-Pattern-as-on-31st-March-2024.pdf 2024-04-20T04:50:25+00:00 0.64 /sites/default/files/Update_on_purchase_of_a_business_undertaking_on_a_slump_sale_arrangement_from_Ivia_Beaute_Private_Limited_India.pdf 2024-04-26T15:46:44+00:00 0.64 /sites/default/files/Share-Reco-Report-Q4-signed.pdf 2024-04-24T11:47:27+00:00 0.64 /sites/default/files/Ig-Certificate-Q4-Signed.pdf 2024-04-21T11:02:15+00:00 0.64 /sites/default/files/Duplicate-Shares-certificate-signed.pdf 2024-04-20T16:07:08+00:00 0.64 /sites/default/files/SE-Intimation-GST-Penalty.pdf 2024-04-19T10:47:37+00:00 0.64 /sites/default/files/Compliance-certificate-under-40-9-signed.pdf 2024-04-19T06:07:04+00:00 0.64 /sites/default/files/Newspaper-Advertisement-of-Notice-of-Postal-Ballot.pdf 2024-04-17T12:58:48+00:00 0.64 /sites/default/files/Stock-Exchange-intimation-for-Notice-of-Postal-Ballot.pdf 2024-04-16T13:55:39+00:00 0.64 /sites/default/files/2024-04/Notice_of_Postal_Ballot.pdf 2024-04-16T11:45:53+00:00 0.64 /sites/default/files/Allotment-of-27906-equity-shares-under-ESOS-2013-A-Scheme-of-the-Company.pdf 2024-04-16T05:41:55+00:00 0.64 /investors/intimation-stock-exchanges?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/Public-Notice-Transfer-of-Equity-Shares-to-IEPF-2023.pdf 2023-09-13T05:57:30+00:00 0.64 /sites/default/files/Public-Notice-Transfer-of-Equity-Shares-to-IEPF-2022.pdf 2023-09-13T05:57:25+00:00 0.64 /sites/default/files/Public-Notice-Transfer-of-Equity-Shares-to-IEPF-2021.pdf 2023-09-13T05:57:23+00:00 0.64 /sites/default/files/Public%20Notice%20%E2%80%93%20Transfer%20of%20Equity%20Shares%20to%20IEPF%20%E2%80%93%20Newspaper%20Publication-2020.pdf 2023-09-13T05:57:19+00:00 0.64 /sites/default/files/bet9��NewspaperPublicationIEPF2019_0.pdf 2023-09-13T05:35:06+00:00 0.64 /sites/default/files/1530083510_Letter-2018.pdf 2023-09-13T05:29:28+00:00 0.64 /sites/default/files/1501758949_Notice-2017.pdf 2023-09-13T05:29:13+00:00 0.64 /sites/default/files/1479889834_Website%20Uplaod-%20Newspaper%20Publication-2016.pdf 2023-09-13T05:28:52+00:00 0.64 /sites/default/files/Press-Release-bet9��-Health-strengthens-its-play-in-beauty-and-personal-care-15th-April-2024.pdf 2024-04-15T16:15:31+00:00 0.64 /sites/default/files/Press-Release-Sanofi-and-bet9��-announce-exclusive-distribution-partnership-to-expand-reach-of-CNS-portfolio-in-India.pdf 2024-03-26T14:46:51+00:00 0.64 /sites/default/files/Press-Release-bet9��-strengthens-fight-against-AMR-secures-approval-to-introduce-ZEMDRI-injection-in-India.pdf 2024-02-26T13:39:17+00:00 0.64 /sites/default/files/Press-Release-bet9��-partners-with-CSIR-CDRI-to-advance-Ophthalmic-Antifungal-Treatment-Development.pdf 2024-02-15T13:29:20+00:00 0.64 /press-releases-statements/cipla-announces-joint-venture-united-states-kemwell-biopharma-and-manipal-education-and-medical-group-for-global-development 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/bet9��-announces-joint-venture-in-the-United-States-with-Kemwell-Biopharma-and-Manipal-Education-and-Medical-Group-for-global-development-and-commercialisation-of-innovative-cell-therapy-products.pdf 2024-01-08T09:10:04+00:00 0.64 /leaders-speak/reimagining-tomorrow 2024-04-29T11:08:51+00:00 0.64 /leaders-speak/reimagining-manufacturing-coming-age-pharmaceutical-industry 2024-04-29T11:08:51+00:00 0.64 /leaders-speak/pharma-operations-40-making-digital-native-organisation 2024-04-29T11:08:51+00:00 0.64 /leaders-speak/preventive-care-clarion-call-entire-healthcare-ecosystem 2024-04-29T11:08:51+00:00 0.64 /leaders-speak/making-india-breathe-free-beyond-covid-19 2024-04-29T11:08:51+00:00 0.64 /leaders-speak/give-joy-get-joy-circle-giving 2024-04-29T11:08:51+00:00 0.64 /leaders-speak?page=1 2024-04-29T11:08:51+00:00 0.64 /csr/cipla-foundation/education.html 2023-09-15T06:05:30+00:00 0.64 /csr/cipla-foundation/skilling.html 2023-09-15T06:05:32+00:00 0.64 /csr/cipla-foundation/environmental-sustainability.html 2023-09-15T06:05:31+00:00 0.64 /csr/cipla-foundation/disaster-response.html 2023-09-15T06:05:30+00:00 0.64 /sites/default/files/Guidance-on-adverse-event-reporting.pdf 2023-09-13T05:54:44+00:00 0.64 /sites/default/files/Adverse_Event_Form.pdf 2024-04-15T13:12:21+00:00 0.64 /careers/life-cipla?page=1 2024-04-29T11:08:51+00:00 0.64 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:31:46+00:00 0.51 /sites/default/files/DAFLR-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:35:51+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/MR-BOCWACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:55:54+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/MT-MBACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:55:58+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:56:31+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T05:59:59+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T06:00:05+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1046.pdf 2023-09-13T06:00:10+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:31:47+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:33:10+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:36:09+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:36:26+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:54:36+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:55:57+00:00 0.51 /sites/default/files/MT-MBACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:55:59+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T05:56:32+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T06:00:02+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T06:00:06+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-852.pdf 2023-09-13T06:00:12+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:31:46+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:33:09+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:36:08+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:54:35+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/MT-MBACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:55:58+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:56:31+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T05:59:59+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T06:00:05+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1050.pdf 2023-09-13T06:00:10+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:31:46+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:33:10+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:36:08+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:54:35+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T05:56:31+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T06:00:00+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T06:00:05+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1059.pdf 2023-09-13T06:00:11+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1060.pdf 2023-09-13T05:31:47+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1060.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1060.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1060.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1060.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1060.pdf 2023-09-13T06:00:01+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1060.pdf 2023-09-13T06:00:06+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1060.pdf 2023-09-13T06:00:11+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:31:47+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:33:10+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:36:08+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:54:36+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/MT-MBACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:55:58+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T05:56:31+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T06:00:01+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T06:00:06+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1064.pdf 2023-09-13T06:00:11+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:31:47+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:33:10+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:36:08+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:36:26+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:54:36+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:55:57+00:00 0.51 /sites/default/files/MT-MBACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:55:59+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T05:56:32+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T06:00:02+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T06:00:06+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1601.pdf 2023-09-13T06:00:12+00:00 0.51 /sites/default/files/ACR-ESIACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:31:47+00:00 0.51 /sites/default/files/AR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:33:10+00:00 0.51 /sites/default/files/DR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:36:08+00:00 0.51 /sites/default/files/EC-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:36:25+00:00 0.51 /sites/default/files/FBERA-ERACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FD-ERACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:37:12+00:00 0.51 /sites/default/files/FR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:54:36+00:00 0.51 /sites/default/files/MR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/OT-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T05:56:31+00:00 0.51 /sites/default/files/WMR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T06:00:02+00:00 0.51 /sites/default/files/WR-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T06:00:06+00:00 0.51 /sites/default/files/WS-CLACT-Nov22-ADE_ST-1065.pdf 2023-09-13T06:00:11+00:00 0.51 /sites/default/files/ACR-ESIACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:31:46+00:00 0.51 /sites/default/files/AR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:33:09+00:00 0.51 /sites/default/files/DR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:36:07+00:00 0.51 /sites/default/files/EC-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:36:23+00:00 0.51 /sites/default/files/FBERA-ERACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:37:09+00:00 0.51 /sites/default/files/FD-ERACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:37:11+00:00 0.51 /sites/default/files/FR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:54:35+00:00 0.51 /sites/default/files/LR-SEACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:55:41+00:00 0.51 /sites/default/files/MR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:55:55+00:00 0.51 /sites/default/files/MT-MBACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:55:57+00:00 0.51 /sites/default/files/OT-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:56:29+00:00 0.51 /sites/default/files/WMR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T05:59:57+00:00 0.51 /sites/default/files/WR-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T06:00:04+00:00 0.51 /sites/default/files/WS-CLACT-Jan23-ADE_ST-852.pdf 2023-09-13T06:00:08+00:00 0.51 /sites/default/files/ACR-ESIACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:31:46+00:00 0.51 /sites/default/files/AR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:33:09+00:00 0.51 /sites/default/files/DELHI_11500194310011099_Mar%2723.pdf 2023-09-13T05:36:00+00:00 0.51 /sites/default/files/DR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:36:07+00:00 0.51 /sites/default/files/EC-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:36:24+00:00 0.51 /sites/default/files/FBERA-ERACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:37:10+00:00 0.51 /sites/default/files/FR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:54:35+00:00 0.51 /sites/default/files/LR-SEACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:55:41+00:00 0.51 /sites/default/files/MR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:55:56+00:00 0.51 /sites/default/files/MT-MBACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:55:58+00:00 0.51 /sites/default/files/OT-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:56:30+00:00 0.51 /sites/default/files/WMR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T05:59:58+00:00 0.51 /sites/default/files/WR-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T06:00:05+00:00 0.51 /sites/default/files/WS-CLACT-Mar23-ADE_ST-852.pdf 2023-09-13T06:00:09+00:00 0.51 /sites/default/files/ACR-ESIACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:31:45+00:00 0.51 /sites/default/files/AR-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:33:08+00:00 0.51 /sites/default/files/DELHI_11500194310011099_APR%2723.pdf 2023-09-13T05:35:59+00:00 0.51 /sites/default/files/DR-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:36:06+00:00 0.51 /sites/default/files/EC-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:36:23+00:00 0.51 /sites/default/files/FBERA-ERACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:37:09+00:00 0.51 /sites/default/files/FR-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:54:34+00:00 0.51 /sites/default/files/LR-SEACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:55:41+00:00 0.51 /sites/default/files/MR-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:55:55+00:00 0.51 /sites/default/files/MT-MBACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:55:57+00:00 0.51 /sites/default/files/OT-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:56:29+00:00 0.51 /sites/default/files/WMR-CLACT-Apr23-ADE_ST-852.pdf 2023-09-13T05:59:56+00:00 0.51